Mar 15 Pharmacology Seminar by Yu Shin Kim
3/15/2018
[Pinn 1-17] Hosted by Bimal Desai, Dr. Yu Shim Kim is an Assistant Professor, Neuroscience, Cell Biology, & Anatomy, The University of Texas Medical Branch, Galveston, Texas About the Speaker: Education and Training PhD in Neuroscience, Johns Hopkins University School of Medicine; Post-Doctoral in Neuroscience, Johns Hopkins University School of Medicine; MS in Biochemistry, Kangwon National University in South Korea; BS in Biochemistry, Kangwon National University in South Korea Research Interests Somatosensory Research: My research focuses on the function and regulation of sensory modalities including pain, itch, and gentle touch. Special objectives in my research are to understand the cellular and molecular mechanisms of pain by studying neural circuit activities evoked by pain in basal and disease conditions. Using cell culture models, spinal cord, brain slices, and live animals, coupled with cell biological, biochemical, and electrophysiological techniques and, multi-photon confocal imaging, I am seeking to understand cellular and molecular mechanisms that mediate biological functions, especially for pain, itch and touch.
Mar 08 Pharmacology Seminar by Heather Ferris
3/8/2018
[Pinn Hall 1-17] Hosted by Thurl Harris, PhD, Heather Ferris is a 2006 UVA alumni, who joined the UVA faculty on May 1st as an Assistant Professor of Medicine in the Division of Endocrinology. She comes to UVA from the Joslin Diabetes Center in Boston...
Feb 06 Pharmacology/NGP Co-Hosted Seminar by Zachary Knight
2/6/2018
[TBD] Hosted by Douglas Bayliss, Pharmacology and the Neurosciences Graduate Program, Dr. Knight is an Assistant Professor in the Department of Physiology and a member of the Kavli Institute for Fundamental Neuroscience at UCSF. His laboratory invest...
12/7/2017
[1st Floor PHCC (Auditorium] A lectureship was established to honor the memory of Joseph Larner, who served as Professor and Chair of the Pharmacology Department for many years. During his time as Chair he recruited and mentored numerous successful faculty, including Al Gilman. He continued to be an inspiration to everyone who knew him, especially our graduate students, who were in awe of his energy and enthusiasm as he kept up his science and maintained an active departmental presence well into his 90s. In addition to honoring Dr. Larner's memory, the goal of this lectureship is to highlight exciting new advances in an area that held great interest for him: the pervasive role of metabolism/cell signaling in human disease. About this Year's Speaker: Hosted by Thurl Harris, Daniel P. Kelly, M.D is the Willard and Rhoda Ware Professor and Director at Penn Cardiovascular Institute, University of Pennsylvania. Dr. Kelly obtained his medical degree from the University of Illinois College of Medicine, residency training at Barnes Hospital in St. Louis, and postdoctoral and clinical cardiology training at Washington University School of Medicine. He joined the Washington University School of Medicine faculty in 1989 and rapidly moved up the ranks to Professor of Medicine, Molecular Biology & Pharmacology, and Pediatrics, and served as Chief of the Cardiovascular Division and founding Director of the Center for Cardiovascular Research. In 2008, Dr. Kelly assumed the role of founding Scientific Director for the east coast Sanford Burnham Prebys Medical Discovery Institute located in Lake Nona, Florida. In August 2017, he moved to the University of Pennsylvania where he was named Director of the Penn Cardiovascular Institute. Dr. Kelly's research interests stem from an early fascination with rare inborn errors in mitochondrial metabolism in children which cause sudden death and heart failure. As a young researcher at Washington University, Dr. Kelly defined the genetic basis for a common inborn error in mitochondrial fatty acid oxidation, work that led to the development of practical screening tests for newborns. Thereafter, he became interested in how similar derangements in cardiac energy metabolism contribute to heart failure and sudden death in common acquired forms of mitochondrial diseases caused by hypertension, ischemic injury, and diabetes. His work defined the transcriptional regulatory axis involved in the control of cardiac fuel and energy metabolism through pioneering fundamental studies on nuclear receptors including the PPARs, estrogen-related receptors (ERRs), and their transcriptional coactivator PGC-1. The Kelly laboratory has identified molecular "switches" in this regulatory pathway that potentially define distinct forms of heart failure, an important step towards identifying therapeutic targets for phenotype-specific treatment of heart failure. His laboratory is also engaged in translation of these discoveries, including early stage drug discovery efforts. Dr. Kelly is a recipient of the American Heart Association Basic Science Prize and currently serves on the Editorial Boards of The Journal of Clinical Investigation and the Journal of the American College of Cardiology-Basic to Translational Science.
12/7/2017
[1st Floor PHCC (Auditorium] A lectureship was established to honor the memory of Joseph Larner, who served as Professor and Chair of the Pharmacology Department for many years. During his time as Chair he recruited and mentored numerous successful faculty, including Al Gilman. He continued to be an inspiration to everyone who knew him, especially our graduate students, who were in awe of his energy and enthusiasm as he kept up his science and maintained an active departmental presence well into his 90s. In addition to honoring Dr. Larner's memory, the goal of this lectureship is to highlight exciting new advances in an area that held great interest for him: the pervasive role of metabolism/cell signaling in human disease. About this Year's Speaker: Hosted by Thurl Harris, Daniel P. Kelly, M.D is the Willard and Rhoda Ware Professor and Director at Penn Cardiovascular Institute, University of Pennsylvania. Dr. Kelly obtained his medical degree from the University of Illinois College of Medicine, residency training at Barnes Hospital in St. Louis, and postdoctoral and clinical cardiology training at Washington University School of Medicine. He joined the Washington University School of Medicine faculty in 1989 and rapidly moved up the ranks to Professor of Medicine, Molecular Biology & Pharmacology, and Pediatrics, and served as Chief of the Cardiovascular Division and founding Director of the Center for Cardiovascular Research. In 2008, Dr. Kelly assumed the role of founding Scientific Director for the east coast Sanford Burnham Prebys Medical Discovery Institute located in Lake Nona, Florida. In August 2017, he moved to the University of Pennsylvania where he was named Director of the Penn Cardiovascular Institute. Dr. Kelly's research interests stem from an early fascination with rare inborn errors in mitochondrial metabolism in children which cause sudden death and heart failure. As a young researcher at Washington University, Dr. Kelly defined the genetic basis for a common inborn error in mitochondrial fatty acid oxidation, work that led to the development of practical screening tests for newborns. Thereafter, he became interested in how similar derangements in cardiac energy metabolism contribute to heart failure and sudden death in common acquired forms of mitochondrial diseases caused by hypertension, ischemic injury, and diabetes. His work defined the transcriptional regulatory axis involved in the control of cardiac fuel and energy metabolism through pioneering fundamental studies on nuclear receptors including the PPARs, estrogen-related receptors (ERRs), and their transcriptional coactivator PGC-1. The Kelly laboratory has identified molecular "switches" in this regulatory pathway that potentially define distinct forms of heart failure, an important step towards identifying therapeutic targets for phenotype-specific treatment of heart failure. His laboratory is also engaged in translation of these discoveries, including early stage drug discovery efforts. Dr. Kelly is a recipient of the American Heart Association Basic Science Prize and currently serves on the Editorial Boards of The Journal of Clinical Investigation and the Journal of the American College of Cardiology-Basic to Translational Science.
Nov 30 “Regulation of Synaptic Transmission by Neuropeptides” by Zhiping Pang
11/30/2017
[Pinn Hall 1-17] Hosted by Michael Scott, Zhiping Pang, PhD is an Assistant Professor and Principal Investigator, Neuroscience and Cell Biology, Child Health Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School Mechanisms of synaptic ...
Nov 10 2017 International Symposium on Neural Modulation & Circuits by Julius Zhu
11/10/2017
[Pinn Hall G1/G2] Free Admission for UVA Faculty, Students and Staff This symposium is sponsored primarly by Luigs&Neumann Feinmechanik and Elektrotechnik GmbH, Ratingen, Germany. Additional funds come from Ted Pella, Inc, Redding, CA, USA, Prizmatix Ltd, Givat Shmuel, Israel, Scientifica Ltd, Uckfield, UK, and Pomega Corporation, Fichburg, WI, USA For more information contact Dr. Julius Zhu (JJZ4N or 243-9246)
Nov 10 2017 International Symposium on Neural Modulation & Circuits by Julius Zhu
11/10/2017
[Pinn Hall G1/G2] Free Admission for UVA Faculty, Students and Staff This symposium is sponsored primarly by Luigs&Neumann Feinmechanik and Elektrotechnik GmbH, Ratingen, Germany. Additional funds come from Ted Pella, Inc, Redding, CA, USA, Prizmatix Ltd, Givat Shmuel, Israel, Scientifica Ltd, Uckfield, UK, and Pomega Corporation, Fichburg, WI, USA For more information contact Dr. Julius Zhu (JJZ4N or 243-9246)
Nov 09 “Molecular Physiology of Cold-activated TRP Channels” by Felix Viana
11/9/2017
[Pinn Hall 5023] Hosted by Douglas Bayliss, Felix Viana, PhD is the Co-director of the Sensory Transduction of Nociception Group, Institute of Neuroscience UMH-CSIC, Alicante, Spain Research Fields: Sensory transduction, focusing on thermotransduct...